George Makrydimas

Prof. Dr. George Makrydimas


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in Genes
Verified
Journal Article
Open access
PDF file
EMEfthalia Moustakli
Efthalia Moustakli
Nektaria ZagorianakouNektaria Zagorianakou
Nektaria Zagorianakou
SMSTYLIANOS MAKRYDIMAS
STYLIANOS MAKRYDIMAS
EOEmmanouil D. Oikonomou
Emmanouil D. Oikonomou
AMAndreas Miltiadous
Andreas Miltiadous
GMGeorge Makrydimas
George Makrydimas
Background/Objectives: Endometriosis is a chronic, estrogen-driven gynecological disorder affecting approximately 10% of reproductive-aged women worldwide, with significant physical, psychosocial, and socioeconomic impacts. Recent research suggests a possible involvement of the gut microbiome in endometriosis disease mechanisms through immune manipulation, estrogen metabolism, and inflammatory networks. This narrative review aims to summarize current evidence on gut microbiota changes in endometriosis patients, explore the mechanisms by which gut dysbiosis contributes to disease progression, and examine epidemiological links between gastrointestinal health and endometriosis risk. Methods: A narrative review was conducted to synthesize available literature on the compositional changes in gut microbiota associated with endometriosis. The review also evaluated studies investigating potential mechanisms and epidemiological patterns connecting gut health with endometriosis development and severity. Results: Alterations in gut microbiota composition were observed in endometriosis patients, suggesting roles in immune dysregulation, estrogen metabolism, and inflammation. Potential gut-oriented interventions, including dietary changes, probiotics, and lifestyle modifications, emerged as promising management options. However, methodological variability and research gaps remain barriers to clinical translation. Conclusions: Integrating gut microbiome research into endometriosis management holds potential for improving early diagnosis, patient outcomes, and healthcare system sustainability. The study emphasizes the need for further research to address existing challenges and to develop public health strategies that incorporate microbiome-based interventions in population-level endometriosis care.

24 November 2022 in Genes
Verified
Journal Article
Open access
PDF file
DESPINA HADJIPANAGIDESPINA HADJIPANAGI
DESPINA HADJIPANAGI
GPGregory Papagregoriou
Gregory Papagregoriou
CKConstantina Koutsofti
Constantina Koutsofti
CPChristiana Polydorou
Christiana Polydorou
PAPolichronis Alivanis
Polichronis Alivanis
Constantinos DeltasConstantinos Deltas
Constantinos Deltas
Alport syndrome (AS) is the most frequent monogenic inherited glomerulopathy and is also genetically and clinically heterogeneous. It is caused by semi-dominant pathogenic variants in the X-linked COL4A5 (NM_000495.5) gene or recessive variants in the COL4A3/COL4A4 (NM_000091.4/NM_000092.4) genes. The disease manifests in early childhood with persistent microhematuria and can progress to proteinuria and kidney failure in adolescence or early adulthood if left untreated. On biopsy, pathognomonic features include alternate thinning, thickening and lamellation of the glomerular basement membrane (GBM), in the presence of podocyte foot process effacement. Although previous studies indicate a prevalence of AS of about 1/50,000, a recent publication reported a predicted rate of pathogenic COL4A5 variants of 1/2320. We herewith present 98 patients (40 M/58 F) from 26 Greek families. We are selectively presenting the families segregating the X-linked form of AS with pathogenic variants in the COL4A5 gene. We found 21 different pathogenic variants, 12 novel: eight glycine and one proline substitutions in the collagenous domain, one cysteine substitution in the NC1 domain, two premature termination of translation codons, three splicing variants, one 5-bp insertion/frameshift variant, one indel-frameshift variant and four gross deletions. Notably, patients in six families we describe here and three families we reported previously, carried the COL4A5-p.G624D substitution, a founder defect encountered all over Europe which is hypomorphic with mostly milder symptomatology. Importantly, on several occasions, the correct genetic diagnosis reclassified patients as patients with AS, leading to termination of previous immunosuppressive/cyclosporine A therapy and a switch to angiotensin converting enzyme inhibitors (ACEi). With the understanding that all 98 patients span a wide range of ages from infancy to late adulthood, 15 patients (11 M/4 F) reached kidney failure and 11 (10 M/1 F) received a transplant. The prospects of avoiding lengthy diagnostic investigations and erroneous medications, and the advantage of delaying kidney failure with very early administration of renin-angiotensin-aldosterone system (RAAS) blockade, highlights the importance of timely documentation of AS by genetic diagnosis.

Verified
Journal Article
Open access
PDF file
EMEfthalia Moustakli
Efthalia Moustakli
Nektaria ZagorianakouNektaria Zagorianakou
Nektaria Zagorianakou
SMSTYLIANOS MAKRYDIMAS
STYLIANOS MAKRYDIMAS
AMAndreas Miltiadous
Andreas Miltiadous
Alexandros T TzallasAlexandros T Tzallas
Alexandros T Tzallas
GMGeorge Makrydimas
George Makrydimas
Analysis of coding areas has long been used to study monogenic illnesses, but despite the extensive use of whole-exome sequencing (WES), up to half of suspected cases remain genetically unexplained. Variants outside coding areas can alter splicing, transcript stability, or gene regulation, compromising normal gene activity. These include mutations in noncoding RNAs, promoters, enhancers, deep intronic sequences, and untranslated regions (UTRs). Several well-known disorders have been linked to these mechanisms, including β-thalassemia caused by deep intronic mutations leading to aberrant splicing, familial hypercholesterolemia caused by promoter defects affecting LDLR expression, and inherited retinal diseases driven by noncoding variants influencing retinal gene regulation. These instances show that pathogenic variation is not limited to the exome and can have significant clinical implications. This review summarizes current understanding of noncoding and regulatory variants in monogenic diseases, discusses how they influence diagnosis and therapy, and highlights integrative approaches combining genomic, transcriptomic, and epigenomic data. Multi-layered research has increased diagnostic accuracy and unveiled new therapeutic potentials, although noncoding variations make the connection between genotype and phenotype more complex. Noncoding regions will need to be incorporated into standard diagnostic procedures to convert molecular insights into concrete therapeutic applications in the future. Predictive algorithms, patient-derived model systems, and functional validation testing will all help to simplify this process.

8 July 2024 in Genes
Verified
Journal Article
Open access
PDF file
ALEXANDROS KATRACHOURASALEXANDROS KATRACHOURAS
ALEXANDROS KATRACHOURAS
HKHarry Kontos
Harry Kontos
KKKyriacos Konis
Kyriacos Konis
CSChara Skentou
Chara Skentou
GMGeorge Makrydimas
George Makrydimas
Non-invasive prenatal testing (NIPT) is usually performed beyond 10 weeks of gestation, because earlier in pregnancy, the fetal fraction is low, resulting in failure to obtain reliable results. This study aimed to evaluate the clinical performance of NIPT earlier in pregnancy using a method for cell-free DNA (cfDNA) analysis that eliminates the need for polymerase chain reaction (PCR), DNA sequencing, or microarrays (Vanadis® system, PerkinElmer, Waltham, MA, USA). Cell-free DNA was extracted from the maternal plasma of 30 singleton pregnancies at 6–9 weeks of gestation (group 1) and at 11–14 weeks of gestation of the same patients (group 2). The mean crown-rump length (CRL) and gestational age in group A was 16.12 mm and that in group B was 61.45 mm. In group A, results were obtained in all, but one, cases (97%). From the remaining pregnancies, one miscarried at 8 weeks and, therefore, the follow-up NIPT at 12 weeks could not be performed. The fetal sex was diagnosed correctly in the 28 cases that had a successful early test, and the results were in accordance with the examination at 12 weeks. There were no cases of aneuploidies and disomy was diagnosed correctly in all. The “Vanadis” prenatal NIPT assay can successfully be used early during the first trimester at 6–9 weeks of gestation (early NIPT) to identify the fetal sex. Further studies are needed to explore the diagnostic potential for aneuploidies.

6 October 2025 in Genes
Verified
Journal Article
Open access
PDF file
Nektaria ZagorianakouNektaria Zagorianakou
Nektaria Zagorianakou
SMSTYLIANOS MAKRYDIMAS
STYLIANOS MAKRYDIMAS
EMEfthalia Moustakli
Efthalia Moustakli
IMIoannis Mitrogiannis
Ioannis Mitrogiannis
EVErmanno Vitale
Ermanno Vitale
GMGeorge Makrydimas
George Makrydimas
Background/Objectives: Gestational weight gain (GWG) is a crucial factor influencing mother and fetal health, as high GWG is associated with adverse pregnancy outcomes and an increased long-term risk of obesity and metabolic issues in the children. In addition to controlling weight, maternal physical activity (PA) during pregnancy may influence fetal development through potential epigenetic mechanisms, including histone modifications, DNA methylation, and the production of non-coding RNA. Methods: This narrative review synthesizes evidence from randomized controlled trials (RCTs; n = 11, 3654 participants) investigating the impact of aerobic PA on GWG, while also highlighting emerging, primarily indirect findings on maternal–fetal epigenetic programming. Results: The majority of RCTs found that supervised PA interventions, especially when paired with nutritional counseling, decreased both the incidence of excessive GWG and total GWG. Enhancements in lipid metabolism, adipokine profiles, and maternal insulin sensitivity point to likely biochemical mechanisms that connect PA to epigenetic modification of fetal metabolic genes (e.g., IGF2, PGC-1α, LEP). Animal and observational studies suggest that maternal activity may influence offspring epigenetic pathways related to obesity and cardiometabolic conditions, although direct human evidence is limited. Conclusions: In addition to potentially changing gene–environment interactions throughout generations, prenatal PA is a low-cost, safe method of improving maternal and newborn health. Future RCTs ought to incorporate molecular endpoints to elucidate the epigenetic processes by which maternal exercise may provide long-term health benefits.

20 January 2025 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Open access
IMIoannis Mitrogiannis
Ioannis Mitrogiannis
CCChristos Chatzakis
Christos Chatzakis
CSChara Skentou
Chara Skentou
SMStylianos Makrydimas
Stylianos Makrydimas
AKAlexandros Katrachouras
Alexandros Katrachouras
GMGeorge Makrydimas
George Makrydimas
To evaluate the amount and types of physical activity (PA) performed by Greek women during pregnancy and assess the validity and reliability of the Greek version of the Pregnancy Physical Activity Questionnaire (PPAQ). This prospective study comprised two stages. The first stage was the completion of the PPAQ Greek version twice, with a one-week interval between the two rounds, to assess internal consistency and reproductivity. The validity was evaluated by comparing the PPAQ results with data from smartwatches that recorded step counts and metabolic equivalent tasks (METs). The second stage included pregnant women from various regions of Greece that completed the PPAQ once during their pregnancy. The level of PA during pregnancy and consistency with the international PA recommendations was evaluated with the use of METs. A total of 1058 pregnant women filled the PPAQ Greek version, while eighteen women randomly participated in the reliability and validity analyses of the PPAQ. Results from the PPAQ completed one week apart showed strong agreement (Intraclass Correlation Coefficient [ICC]: 0.82-0.96). A comparison between the PPAQ results and smartwatch data revealed no significant differences in PA levels (correlation coefficient: 0.542; p = 0.022). The median total PA for all the participants was 142.1 MET-hours/week (interquartile range: 106.04 MET-hours/week). PA levels increased with advancing gestation in sports/exercise (1st vs. 2nd trimester, p = 0.048; 2nd vs. 3rd trimester, p < 0.001), occupational activities (1st vs. 3rd trimester, p < 0.001; 2nd vs. 3rd trimester, p = 0.024), and transportation activities (1st vs. 3rd trimester, p < 0.001; 2nd vs. 3rd trimester, p < 0.001). Moderate-to-vigorous intensity activities also increased with gestational age (p = 0.023, 95 % confidence interval [CI]: 0.1-1.4; p = 0.045, 95 % CI: 0-0.08, respectively). Women were more active in household/caregiving activities across all trimesters (p = 0.017; 95 % CI: 0.09-0.95). Women with higher educational levels were more likely to engage in sports/exercise (p = 0.039, 95 % CI: -3.3 to -0.08) and had higher overall PA levels (p = 0.029, 95 % CI: 0.37-6.3). However, only 14.8 % of the participants met the international PA recommendations for pregnancy. The Greek version of the PPAQ is a reliable tool for assessing PA in pregnant Greek women. Higher educational levels and advanced gestational age were found to be associated with increased PA levels. However, only a small proportion of pregnant Greek women met the international PA recommendations, highlighting the need for targeted interventions.